Novavax to Begin Clinical Testing of Coronavirus Vaccine by Late Spring

Novavax (NASDAQ: NVAX) announced on Wednesday that it's advancing its development of an experimental vaccine for COVID-19, the disease caused by the coronavirus strain that continues to spread across the world.